Imaging technique could replace tissue biopsies in assessing drug resistance in cancer

Imaging techniques could replace the need for invasive tissue biopsies in helping rapidly determine whether cancer treatments are working effectively, according to researchers at the University of Cambridge. In a study published in the journal Cancer Cell, researchers at the Cancer Research UK (CRUK) Cambridge Institute have shown how a new technique known as hyperpolarisation—which involves effectively magnetizing molecules in […]

» Read more

Study suggests link between pediatric hospitalization and rising unemployment

Pediatric hospitalization rates increase when unemployment levels rise, suggests a National Institutes of Health-funded analysis of data from 14 states spanning 12 years. For every 1% increase in unemployment, researchers saw a 5% increase in hospitalizations for substance abuse, a 4% increase for diabetes, a 2% increase for poisoning and burns, and a 2% increase for children with medical complexity—those […]

» Read more

Wearing a Mask Doesn’t Cause CO2 Poisoning

TUESDAY, Oct. 6, 2020 — Wearing a face mask cannot lead to carbon dioxide poisoning, even in people with lung disease, researchers report. The findings counter claims that wearing face masks to prevent spread of the new coronavirus may put some people’s health at risk. The authors of the new study assessed changes in oxygen or carbon dioxide levels in […]

» Read more

Researchers characterize the gene responsible for immune cell death and inflammation during sepsis

Sepsis is caused by the immune system going into over-drive in response to infection. It leads to extreme inflammation that can cause blood clots and block oxygen from reaching vital organs, resulting in tissue death and multiple organ failure. Researchers from La Trobe University in Melbourne, Australia have identified and characterized the gene responsible for immune cell death and inflammation […]

» Read more

CGH & IHiS develop AI tool to predict severity of pneumonia in patients

Changi General Hospital (CGH), a 1000-bed academic medical institution under SingHealth located in the eastern part of Singapore, together with the Integrated Health Information System (IHiS), Singapore’s national HIT agency, have developed a Community Acquired Pneumonia and COVID-19 Artificial Intelligence (AI) Predictive Engine (CAPE) that can determine the likelihood of whether the patient has mild or severe pneumonia, based on […]

» Read more

COVID-19 Vaccine AZD1222 Clinical Trial Resumed in Japan, Follows Restart of Trials in the UK, Brazil, South Africa and India

2 October 2020 — The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). A standard review process triggered a voluntary pause to vaccination across all global trials on 6 September to allow review of safety data by an independent committee. Their recommendations have been […]

» Read more

Casey Goode's Husband Gives Update on Newborn Son's Condition After COVID-19 Diagnosis

Casey Goode's husband Alex is opening up about their son's condition after the newborn tested positive for the novel coronavirus shortly following his release from the neonatal intensive care unit. The Bar Rescue expert gave fans an update on Maximillian's hospitalization on Monday, writing in the caption of a video on his Instagram Stories, "Mama & Max will stay in […]

» Read more

Discovery holds potential for reversing vision loss

An Oklahoma Medical Research Foundation discovery could pave the way for therapies to reverse vision loss common in premature infants and adults. In a new study appearing in the Proceedings of the National Academy of Sciences, OMRF scientists have identified a compound that could give birth to therapies for a host of eye diseases that include retinopathy of prematurity and […]

» Read more

Preliminary results of two large immune therapy studies show promise in advanced cervical cancer

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women. David O’Malley, MD, of The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard […]

» Read more
1 1,138 1,139 1,140 1,141 1,142 1,330